Douglas S. Ingram

President & Chief Executive Officer at Sarepta Therapeutics, Inc.

Douglas S. Ingram

Douglas S. Ingram

President & Chief Executive Officer at Sarepta Therapeutics, Inc.

Overview
Career Highlights

Allergan, Inc.
Sarepta Therapeutics, Inc.
Chase Pharmaceuticals Corp.

RelSci Relationships

903

Number of Boards

13

Birthday

1963

Age

58

Relationships
RelSci Relationships are individuals Douglas S. Ingram likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at International Council of Ophthalmology Foundation

Relationship likelihood: Strong

Former Chief Medical Officer at Valeant Pharmaceuticals International Corp.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Relay Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman & Co-Founder at Skye Bioscience, Inc.

Relationship likelihood: Strong

Executive Vice President, Human Resources at Ingram Micro, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Skye Bioscience, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Conexant Systems LLC

Relationship likelihood: Strong

Former Chief Financial Officer at Eureka Bank (Pittsburgh, Pennsylvania)

Relationship likelihood: Strong

Former President, Chief Operating Officer & Director at East West Bancorp, Inc.

Relationship likelihood: Strong

Paths to Douglas S. Ingram
Potential Connections via
Relationship Science
You
Douglas S. Ingram
President & Chief Executive Officer at Sarepta Therapeutics, Inc.
Education
Undergraduate Degree
Class of 1985

Arizona State University (commonly referred to as ASU or Arizona State) is a national space-grant institution and public metropolitan research university located in the Phoenix Metropolitan Area of Arizona. ASU is the largest public university in the United States by enrollment. Founded in 1885 as the Tempe Normal School for the Arizona Territory, the school came under control of the Arizona Board of Regents in 1945 and was renamed Arizona State College. A 1958 statewide ballot measure gave the university its present name, making Arizona State one of the nation's newest public research universities.

JD

James E. Rogers College of Law is the law school at the University of Arizona located in Tucson, Arizona and was the first law school founded in the State of Arizona, opening its doors in 1915. Formerly known as University of Arizona College of Law, it was renamed in 1999 in honor of noted broadcasting executive and philanthropist James E. Rogers, a 1962 graduate of the school, and chairman of Sunbelt Communications Company based in Las Vegas, Nevada. The core values of the College are justice, professional integrity, public leadership, and community service. Each entering class at Arizona Law has approximately 150 students, with a total student body of 500 students.

Career History
President & Chief Executive Officer
2017 - Current

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

President, Chief Executive Officer & Director
2015 - 2016

Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC.

Special Advisor
2015 - 2015

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Boards & Committees
Director
Prior - 2015
Transactions
Details Hidden

Chase Pharmaceuticals Corp. raised money in a private placement transaction

Details Hidden

Chase Pharmaceuticals Corp. raised money in a private placement transaction

Details Hidden

Chase Pharmaceuticals Corp. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Douglas S. Ingram. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Douglas S. Ingram's profile does not indicate a business or promotional relationship of any kind between RelSci and Douglas S. Ingram.